Trials / Completed
CompletedNCT01004315
A Confirmatory Study of KUC-7483 in Patients With Overactive Bladder
A Randomized, Double Blind, Placebo Controlled, Phase III Study of KUC-7483 in Patients With Overactive Bladder
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 750 (estimated)
- Sponsor
- Kissei Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy and the safety of KUC-7483 in overactive bladder patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KUC-7483 | |
| DRUG | Placebo | |
| DRUG | Tolterodine |
Timeline
- First posted
- 2009-10-29
- Last updated
- 2010-07-27
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01004315. Inclusion in this directory is not an endorsement.